Park Seong-Cheol, Park Yoonkyung, Hahm Kyung-Soo
Research Center for Proteineous Materials, Chosun University, Gwangju 501-759, Korea; E-Mails:
Int J Mol Sci. 2011;12(9):5971-92. doi: 10.3390/ijms12095971. Epub 2011 Sep 16.
Over the last decade, decreasing effectiveness of conventional antimicrobial-drugs has caused serious problems due to the rapid emergence of multidrug-resistant pathogens. Furthermore, biofilms, which are microbial communities that cause serious chronic infections and dental plaque, form environments that enhance antimicrobial resistance. As a result, there is a continuous search to overcome or control such problems, which has resulted in antimicrobial peptides being considered as an alternative to conventional drugs. Antimicrobial peptides are ancient host defense effector molecules in living organisms. These peptides have been identified in diverse organisms and synthetically developed by using peptidomimic techniques. This review was conducted to demonstrate the mode of action by which antimicrobial peptides combat multidrug-resistant bacteria and prevent biofilm formation and to introduce clinical uses of these compounds for chronic disease, medical devices, and oral health. In addition, combinations of antimicrobial peptides and conventional drugs were considered due to their synergetic effects and low cost for therapeutic treatment.
在过去十年中,由于多重耐药病原体的迅速出现,传统抗菌药物有效性的降低引发了严重问题。此外,生物膜作为导致严重慢性感染和牙菌斑的微生物群落,形成了增强抗菌耐药性的环境。因此,人们不断寻求克服或控制此类问题的方法,这使得抗菌肽被视为传统药物的替代品。抗菌肽是生物体中古老的宿主防御效应分子。这些肽已在多种生物体中被鉴定出来,并通过肽模拟技术进行了合成开发。本综述旨在阐述抗菌肽对抗多重耐药细菌以及预防生物膜形成的作用方式,并介绍这些化合物在慢性病、医疗器械和口腔健康方面的临床应用。此外,由于抗菌肽与传统药物的协同作用以及治疗成本较低,还对它们的联合使用进行了探讨。